Equities analysts forecast that MAXIMUS, Inc. (NYSE:MMS) will announce earnings per share of $0.76 for the current fiscal quarter, Zacks reports. Four analysts have provided estimates for MAXIMUS’s earnings. The highest EPS estimate is $0.78 and the lowest is $0.75. MAXIMUS posted earnings of $0.77 per share during the same quarter last year, which would indicate a negative year-over-year growth rate of 1.3%. The business is expected to announce its next quarterly earnings report on Thursday, November 9th.

On average, analysts expect that MAXIMUS will report full year earnings of $3.13 per share for the current fiscal year, with EPS estimates ranging from $3.12 to $3.14. For the next fiscal year, analysts forecast that the firm will post earnings of $3.23 per share, with EPS estimates ranging from $3.15 to $3.30. Zacks Investment Research’s EPS averages are a mean average based on a survey of sell-side research firms that that provide coverage for MAXIMUS.

MAXIMUS (NYSE:MMS) last announced its earnings results on Thursday, August 3rd. The health services provider reported $0.79 EPS for the quarter, topping the consensus estimate of $0.76 by $0.03. The firm had revenue of $600.40 million for the quarter, compared to the consensus estimate of $614.12 million. MAXIMUS had a net margin of 9.62% and a return on equity of 26.77%. The business’s quarterly revenue was down 2.7% on a year-over-year basis. During the same period last year, the company posted $0.79 EPS.

A number of research analysts have recently commented on MMS shares. BidaskClub cut MAXIMUS from a “strong-buy” rating to a “buy” rating in a research note on Thursday, July 6th. Zacks Investment Research upgraded MAXIMUS from a “hold” rating to a “buy” rating and set a $68.00 target price for the company in a research note on Saturday, August 5th. Maxim Group set a $66.00 target price on MAXIMUS and gave the company a “hold” rating in a research note on Thursday, August 3rd. ValuEngine cut MAXIMUS from a “buy” rating to a “hold” rating in a research note on Tuesday, May 16th. Finally, Jefferies Group LLC cut MAXIMUS from a “buy” rating to a “hold” rating and raised their target price for the company from $63.00 to $64.00 in a research note on Friday, May 5th. One analyst has rated the stock with a sell rating and eight have assigned a hold rating to the company. MAXIMUS presently has a consensus rating of “Hold” and a consensus price target of $62.17.

In related news, Director Paul R. Lederer sold 2,200 shares of MAXIMUS stock in a transaction on Monday, August 14th. The stock was sold at an average price of $60.87, for a total value of $133,914.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, General Counsel David Francis sold 2,000 shares of MAXIMUS stock in a transaction on Friday, August 18th. The stock was sold at an average price of $58.89, for a total value of $117,780.00. Following the completion of the sale, the general counsel now directly owns 13,716 shares of the company’s stock, valued at approximately $807,735.24. The disclosure for this sale can be found here. Insiders sold 118,342 shares of company stock valued at $7,247,617 in the last 90 days. Company insiders own 3.10% of the company’s stock.

Hedge funds have recently modified their holdings of the company. Neuburgh Advisers LLC raised its stake in shares of MAXIMUS by 1.9% in the first quarter. Neuburgh Advisers LLC now owns 1,696 shares of the health services provider’s stock valued at $105,000 after buying an additional 32 shares during the last quarter. Acrospire Investment Management LLC raised its stake in shares of MAXIMUS by 183.3% in the first quarter. Acrospire Investment Management LLC now owns 1,700 shares of the health services provider’s stock valued at $106,000 after buying an additional 1,100 shares during the last quarter. Glen Harbor Capital Management LLC raised its stake in shares of MAXIMUS by 1.9% in the first quarter. Glen Harbor Capital Management LLC now owns 2,332 shares of the health services provider’s stock valued at $145,000 after buying an additional 44 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of MAXIMUS by 10.2% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,367 shares of the health services provider’s stock valued at $148,000 after buying an additional 220 shares during the last quarter. Finally, First Bank & Trust raised its stake in shares of MAXIMUS by 4.2% in the second quarter. First Bank & Trust now owns 2,507 shares of the health services provider’s stock valued at $157,000 after buying an additional 101 shares during the last quarter. 97.20% of the stock is owned by institutional investors.

Shares of MAXIMUS (NYSE:MMS) traded down 0.85% during mid-day trading on Friday, reaching $59.36. 304,720 shares of the company’s stock traded hands. The company has a market cap of $3.85 billion, a price-to-earnings ratio of 19.03 and a beta of 1.39. MAXIMUS has a 12 month low of $43.69 and a 12 month high of $64.97. The company has a 50 day moving average of $60.48 and a 200 day moving average of $61.15.

The firm also recently declared a quarterly dividend, which will be paid on Thursday, August 31st. Stockholders of record on Tuesday, August 15th will be paid a $0.045 dividend. This represents a $0.18 annualized dividend and a dividend yield of 0.30%. The ex-dividend date of this dividend is Friday, August 11th. MAXIMUS’s dividend payout ratio is currently 5.73%.

ILLEGAL ACTIVITY NOTICE: “Zacks: Brokerages Expect MAXIMUS, Inc. (MMS) Will Post Earnings of $0.76 Per Share” was first posted by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are reading this story on another site, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright laws. The legal version of this story can be read at https://theolympiareport.com/2017/08/27/zacks-brokerages-expect-maximus-inc-mms-will-post-earnings-of-0-76-per-share.html.

MAXIMUS Company Profile

MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.

Get a free copy of the Zacks research report on MAXIMUS (MMS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for MAXIMUS (NYSE:MMS)

Receive News & Ratings for MAXIMUS Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.